Gene Therapy Services
ProBio provides end-to-end gene therapy solutions, from plasmid and viral vector
process development to GMP manufacturing and analytical support.
Our scalable platforms enable efficient delivery of AAV for clinical
and commercial programs.
process development to GMP manufacturing and analytical support.
Our scalable platforms enable efficient delivery of AAV for clinical
and commercial programs.
Our Services & Solutions
End-to-end gene therapy CDMO services enabling rapid advancement from early research to clinical and commercial production.
ProBio Gene Therapy Solutions to Support at All Stages
Plasmid CDMO
AAssistV™ Plasmid
AAV CDMO
Pre-clinical Development
PreCMC Plasmid
PreCMC Grade
Pro AAV Vector
IND Filing
Plasmid IND-enabling CMC
DMF LOA
AAV Vector IND-enabling CMC
Early Stage Clinical (I, II, III)
GMP-Principle Plasmid
GMP-Principle Grade
Clinical GMP AAV Vector
Late Stage Clinical (BLA/NDA)
GMP Plasmid
GMP Grade
GMP AAV Vector
BLA PC/PV
BLA Dossier
BLA PC/PV
Commercial
GMP Plasmid
GMP Grade
GMP AAV Vector
Pre-clinical Development
IND Filing
Early Stage Clinical (I, II, III)
Late Stage Clinical (BLA/NDA)
Commercial
Plasmid CDMO
AAssistV™ Plasmid
AAV CDMO
PreCMC Plasmid
PreCMC Grade
Pro AAV Vector
Plasmid IND-enabling CMC
DMF LOA
AAV Vector IND-enabling CMC
GMP-Principle Plasmid
GMP-Principle Grade
Clinical GMP AAV Vector
GMP Plasmid
GMP Grade
GMP AAV Vector
BLA PC/PV
BLA Dossier
BLA PC/PV
GMP Plasmid
GMP Grade
GMP AAV Vector
Fast, Scalable, Platform-Driven AAV Manufacturing from Early Research Through to Commercialization
ProBio CDMO Expands Viral Vector Development Capabilities at US site with New Packaging Test Platform
The new Viral Vector Packaging Test provides feasibility level data to support vector design, manufacturability, and scalability decisions at a critical inflection point in development.
Learn More
From Plasmid to AAV Clinical Manufacturing in as Little as 6 Weeks
From AAV plasmid, to viral vector production, our robust and scalable platform supports gene therapy manufacturing up to 200L.
Learn More
Viral Vector Packaging Test - Seamless Transition from Discovery to CMC
In cell and gene therapy programs, early-stage decisions often carry long-term implications. ProBio’s packaging test aims to support the delivery of feasibility-level data and technical confidence to inform next steps.
Learn More
US
ProBio's GMP Facility in New Jersey
China
ProBio's Flagship in Nanjing
Europe
ProBio's Client Liaison in EMEA
APAC
ProBio in Korea, Japan & Singapore